Literature DB >> 28154905

Changes in dorsolateral prefrontal connectivity after rTMS in treatment-resistant depression: a brain perfusion SPECT study.

Raphaëlle Richieri1,2, Damien Jouvenoz3, Antoine Verger4,5, Patrick Fiat1,2, Laurent Boyer2,6, Christophe Lançon1,2, Eric Guedj7,8,9.   

Abstract

PURPOSE: Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive and safe alternative to electroconvulsive therapy for treatment-resistant depression (TRD). After rTMS, changes in brain SPECT perfusion have been remotely identified within medial temporal limbic areas, while no local effects have been found within the left dorsolateral prefrontal cortex (DLPFC)-i.e. under the coil. Functional changes in connectivity may underlie these remote effects. Interestingly, functional connectivity has been recently investigated using perfusion SPECT, and abnormalities identified in TRD patients. The aim of the present study is to evaluate perfusion and connectivity SPECT changes in TRD patients after rTMS of the left DLPFC. We hypothesize that changes in DLPFC networks may explain remote hypoperfusions found after rTMS.
METHODS: Fifty-eight TRD patients underwent a brain SPECT before and after high-frequency rTMS of the left DLPFC. Whole-brain voxel-based changes in perfusion were evaluated with SPM8, and inter-regional correlation analysis performed to study left DLPFC functional connectivity (p < 0.005, corrected for cluster volume).
RESULTS: After rTMS, patients were significantly improved on Beck Depression Inventory score (p < 0.0001). Considering a 50% reduction threshold, 27 patients were identified as responders (47%). After rTMS, perfusion changes were not found locally within the left DLPFC, but remotely within the bilateral temporal lobes, including limbic areas. Inter-regional correlation SPECT analysis brings out a decrease of connectivity between the left DLPFC and both the cingulate/medial frontal cortex and bilateral medial temporal limbic areas, in relation with the clinical response.
CONCLUSIONS: rTMS of DLPFC in TRD patients leads to remote temporal hypoperfusions in relation with changes in functional connectivity between the DLPFC and the default mode network, especially including medial temporal limbic areas.

Entities:  

Keywords:  Connectivity; Repetitive transcranial magnetic stimulation (rTMS); SPM; Single-photon emission computed tomography (SPECT); Treatment-resistant depression

Mesh:

Year:  2017        PMID: 28154905     DOI: 10.1007/s00259-017-3640-5

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  12 in total

1.  Pathological gambling in patients with Parkinson's disease is associated with fronto-striatal disconnection: a path modeling analysis.

Authors:  Roberto Cilia; Sang Soo Cho; Thilo van Eimeren; Giorgio Marotta; Chiara Siri; Ji Hyun Ko; Giovanna Pellecchia; Gianni Pezzoli; Angelo Antonini; Antonio P Strafella
Journal:  Mov Disord       Date:  2011-01-31       Impact factor: 10.338

2.  EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2.

Authors:  Ozlem L Kapucu; Flavio Nobili; Andrea Varrone; Jan Booij; Thierry Vander Borght; Kjell Någren; Jacques Darcourt; Klaus Tatsch; Koen J Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12       Impact factor: 9.236

3.  Default-mode network connectivity and white matter burden in late-life depression.

Authors:  Minjie Wu; Carmen Andreescu; Meryl A Butters; Robert Tamburo; Charles F Reynolds; Howard Aizenstein
Journal:  Psychiatry Res       Date:  2011-08-06       Impact factor: 3.222

Review 4.  Treatment resistant depression in the elderly: a review of its conceptualisation, management and relationship to organic brain disease.

Authors:  R C Baldwin; S Simpson
Journal:  J Affect Disord       Date:  1997-12       Impact factor: 4.839

5.  Determinants of brain SPECT perfusion and connectivity in treatment-resistant depression.

Authors:  Raphaëlle Richieri; Laurent Boyer; Catherine Faget-Agius; Jean Farisse; Olivier Mundler; Christophe Lançon; Eric Guedj
Journal:  Psychiatry Res       Date:  2014-12-03       Impact factor: 3.222

6.  Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus.

Authors:  Michael D Greicius; Benjamin H Flores; Vinod Menon; Gary H Glover; Hugh B Solvason; Heather Kenna; Allan L Reiss; Alan F Schatzberg
Journal:  Biol Psychiatry       Date:  2007-01-08       Impact factor: 13.382

7.  A treatment-resistant default mode subnetwork in major depression.

Authors:  Baojuan Li; Li Liu; Karl J Friston; Hui Shen; Lubin Wang; Ling-Li Zeng; Dewen Hu
Journal:  Biol Psychiatry       Date:  2012-12-27       Impact factor: 13.382

8.  Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study.

Authors:  Marie-Laure Paillère Martinot; André Galinowski; Damien Ringuenet; Thierry Gallarda; Jean-Pascal Lefaucheur; Frank Bellivier; Christine Picq; Pascale Bruguière; Jean-François Mangin; Denis Rivière; Jean-Claude Willer; Bruno Falissard; Marion Leboyer; Jean-Pierre Olié; Eric Artiges; Jean-Luc Martinot
Journal:  Int J Neuropsychopharmacol       Date:  2009-03-09       Impact factor: 5.176

9.  Default mode network mechanisms of transcranial magnetic stimulation in depression.

Authors:  Conor Liston; Ashley C Chen; Benjamin D Zebley; Andrew T Drysdale; Rebecca Gordon; Bruce Leuchter; Henning U Voss; B J Casey; Amit Etkin; Marc J Dubin
Journal:  Biol Psychiatry       Date:  2014-02-05       Impact factor: 13.382

10.  Equivalent brain SPECT perfusion changes underlying therapeutic efficiency in pharmacoresistant depression using either high-frequency left or low-frequency right prefrontal rTMS.

Authors:  Raphaëlle Richieri; Laurent Boyer; Romain Padovani; Marc Adida; Cécile Colavolpe; Olivier Mundler; Christophe Lançon; Eric Guedj
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-07-29       Impact factor: 5.067

View more
  6 in total

1.  Dorsolateral prefrontal γ-aminobutyric acid in patients with treatment-resistant depression after transcranial magnetic stimulation measured with magnetic resonance spectroscopy

Authors:  Jennifer G. Levitt; Guldamla Kalender; Joseph O’Neill; Joel P. Diaz; Ian A. Cook; Nathaniel Ginder; David Krantz; Michael J. Minzenberg; Nikita Vince-Cruz; Lydia D. Nguyen; Jeffry R. Alger; Andrew F. Leuchter
Journal:  J Psychiatry Neurosci       Date:  2019-11-01       Impact factor: 6.186

2.  Elevated expression of unfolded protein response genes in the prefrontal cortex of depressed subjects: Effect of suicide.

Authors:  Yuta Yoshino; Yogesh Dwivedi
Journal:  J Affect Disord       Date:  2019-11-05       Impact factor: 4.839

Review 3.  Benefits from Repetitive Transcranial Magnetic Stimulation in Post-Stroke Rehabilitation.

Authors:  Michał Starosta; Natalia Cichoń; Joanna Saluk-Bijak; Elżbieta Miller
Journal:  J Clin Med       Date:  2022-04-12       Impact factor: 4.964

Review 4.  Mechanism of Repetitive Transcranial Magnetic Stimulation for Depression.

Authors:  Zhengwu Peng; Cuihong Zhou; Shanshan Xue; Jie Bai; Shoufen Yu; Xiaosa Li; Huaning Wang; Qingrong Tan
Journal:  Shanghai Arch Psychiatry       Date:  2018-04-25

5.  Neuroimaging mechanisms of high-frequency repetitive transcranial magnetic stimulation for treatment of amnestic mild cognitive impairment: a double-blind randomized sham-controlled trial.

Authors:  Li-Qiong Yuan; Qing Zeng; Dan Wang; Xiu-Yun Wen; Yu Shi; Fen Zhu; Shang-Jie Chen; Guo-Zhi Huang
Journal:  Neural Regen Res       Date:  2021-04       Impact factor: 5.135

6.  Depressive symptoms reduce when dorsolateral prefrontal cortex-precuneus connectivity normalizes after functional connectivity neurofeedback.

Authors:  Jessica Elizabeth Taylor; Takashi Yamada; Takahiko Kawashima; Yuko Kobayashi; Yujiro Yoshihara; Jun Miyata; Toshiya Murai; Mitsuo Kawato; Tomokazu Motegi
Journal:  Sci Rep       Date:  2022-02-16       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.